Dong-A Pharmaceutical announced on the 10th that it has introduced Diphan Cure, a treatment for infantile eczema. Infants have thin skin barriers and are easily exposed to skin diseases. Diphan Cure helps alleviate allergic inflammation and skin irritation. It contains the steroid ingredients hydrocortisone and dexpanthenol.
Hanmi Group announced on the 10th that it has delivered 10 million won in donations to patients with severe illnesses such as Director General Syndrome, liver cancer, breast cancer, and cerebral infarction. This is part of their social contribution program. Support is provided for living expenses, treatment costs, and educational fees for the patients.
Yuhan Corporation announced on the 10th that it has recently launched its youth social innovation program, the "Unique Academy." Thirty university students and job seekers will explore social issues in the health and welfare sector and plan solutions over five weeks. Yuhan Corporation CEO Jo Uk-je said, "I hope that young people will define and solve social issues on their own, discovering their potential and sense of social responsibility in the process."
Dong-A ST's affiliate Metavia announced on the 10th that it has started an additional Phase 1 clinical trial to explore the maximum tolerated dose of 'DA-1726,' which is being developed as an obesity treatment. This will be conducted over four weeks with healthy obese adults receiving repeated doses of DA-1726 or a placebo.
GC Cell announced on the 10th that it has signed a contract with Duesel for the contract development and manufacturing of the biopharmaceutical 'DCB-101 (en-aPLT™).' This is an artificial platelet derived from stem cells. GC Cell will support the production of artificial platelets by Duesel. The company stated, "We will ensure that the pipeline enters clinical trials smoothly."
Cha University announced on the 19th that it has begun cooperation with Dongyang University, Pocheon, Dongducheon, and Yeoncheon in Gyeonggi Province to develop balanced growth and educational development special zone projects in the northern Gyeonggi area. The aim is to cultivate specialized talent suited to regional industries. A collaborative system involving universities, corporations, research institutes, local governments, citizens, and startups will be established.